Source-grounded facts extracted from Omada Health, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Omada Health, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-16 meeting.
“Proposal Two – Ratification of the Appointment of Independent Registered Public Accounting Firm FOR AGAINST ABSTAIN 41,550,689 16,905 27,282”
Omada Health, Inc. shareholders approved Election of Class I Directors: Sean Duffy and Trevor Fetter at the 2026-06-16 meeting.
“The final voting results for each of these proposals are as follows: Proposal One - Election of Class I Directors NOMINEE FOR WITHHELD BROKER NON-VOTERS Sean Duffy 18,540,089 9,134,162 13,920,625 Trevor Fetter 18,538,042 9,136,209 13,920,625”
Omada Health, Inc. reported first quarter ended March 31, 2026 results: revenue $78 million in the first quarter, net income Net loss of $3 million in the first quarter.
“million Total Members at the end of Q1, up 51% year over year, reinforcing Omada’s role as an integrated, multi-condition cardiometabolic platform operating at scale. • Revenue: $78 million in the first quarter, up 42% year over year. • Omada joined Optum Rx’s Weight Engage portfolio to help employers expand responsible, clinically supported access to GLP‐1 and”
Omada Health, Inc. reported the full year ended December 31, 2025 results: revenue $260 million, net income net loss of $13 million.
“and full year 2025, except where otherwise noted. Total members • 886,000 at year end, up 55% year over year Revenue • $76 million in the fourth quarter, up 58% year over year • $260 million for the full year, up 53% compared with 2024 GLP-1 Leadership • Omada has now supported more than 150,000 members on GLP-1s, compared with more than 50,000 at the end of 2024 •”
Omada Health, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $76 million, net income $5 million.
“Revenue • $76 million in the fourth quarter, up 58% year over year • $260 million for the full year, up 53% compared with 2024”
Omada Health, Inc.: Amended and restated bylaws became effective in connection with IPO closing (effective 2025-06-09).
“its amended and restated bylaws (the “Bylaws”) became effective in connection with the closing of the initial public offering of shares of the Company’s common stock”
Omada Health, Inc.: Restated certificate of incorporation filed in connection with IPO closing (effective 2025-06-09).
“On June 9, 2025, Omada Health, Inc. (the “Company”) filed its restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.